Does TACROLIMUS Cause Acute graft versus host disease? 686 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 686 reports of Acute graft versus host disease have been filed in association with TACROLIMUS (Tacrolimus). This represents 0.8% of all adverse event reports for TACROLIMUS.
686
Reports of Acute graft versus host disease with TACROLIMUS
0.8%
of all TACROLIMUS reports
208
Deaths
105
Hospitalizations
How Dangerous Is Acute graft versus host disease From TACROLIMUS?
Of the 686 reports, 208 (30.3%) resulted in death, 105 (15.3%) required hospitalization, and 35 (5.1%) were considered life-threatening.
Is Acute graft versus host disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TACROLIMUS. However, 686 reports have been filed with the FAERS database.
What Other Side Effects Does TACROLIMUS Cause?
Off label use (8,718)
Drug ineffective (6,214)
Product use in unapproved indication (5,057)
Acute kidney injury (4,005)
Transplant rejection (3,526)
Cytomegalovirus infection (3,320)
Covid-19 (3,201)
Drug interaction (2,896)
Diarrhoea (2,854)
Toxicity to various agents (2,845)
What Other Drugs Cause Acute graft versus host disease?
CYCLOSPORINE (1,043)
MYCOPHENOLATE MOFETIL (1,021)
FLUDARABINE (715)
CYCLOPHOSPHAMIDE (710)
METHOTREXATE (656)
BUSULFAN (337)
THIOTEPA (331)
LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (245)
RUXOLITINIB (240)
MELPHALAN (224)
Which TACROLIMUS Alternatives Have Lower Acute graft versus host disease Risk?
TACROLIMUS vs TACROLIMUS\TACROLIMUS ANHYDROUS
TACROLIMUS vs TADALAFIL
TACROLIMUS vs TAFAMIDIS
TACROLIMUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS vs TAFASITAMAB